BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bowerman KL, Rehman SF, Vaughan A, Lachner N, Budden KF, Kim RY, Wood DLA, Gellatly SL, Shukla SD, Wood LG, Yang IA, Wark PA, Hugenholtz P, Hansbro PM. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. Nat Commun 2020;11:5886. [PMID: 33208745 DOI: 10.1038/s41467-020-19701-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 75] [Article Influence: 22.3] [Reference Citation Analysis]
Number Citing Articles
1 Dasgupta S, Ghosh N, Bhattacharyya P, Roy Chowdhury S, Chaudhury K. Metabolomics of asthma, COPD, and asthma-COPD overlap: an overview. Crit Rev Clin Lab Sci 2023;60:153-70. [PMID: 36420874 DOI: 10.1080/10408363.2022.2140329] [Reference Citation Analysis]
2 Tokuno H, Itoga T, Kasuga J, Okuma K, Hasuko K, Masuyama H, Benno Y. Method for estimating disease risk from microbiome data using structural equation modeling. Front Microbiol 2023;14. [DOI: 10.3389/fmicb.2023.1035002] [Reference Citation Analysis]
3 Kayongo A, Robertson NM, Siddharthan T, Ntayi ML, Ndawula JC, Sande OJ, Bagaya BS, Kirenga B, Mayanja-kizza H, Joloba ML, Forslund SK. Airway microbiome-immune crosstalk in chronic obstructive pulmonary disease. Front Immunol 2023;13. [DOI: 10.3389/fimmu.2022.1085551] [Reference Citation Analysis]
4 Nuccio DA, Normann MC, Zhou H, Grippo AJ, Singh P. Microbiome and Metabolome Variation as Indicator of Social Stress in Female Prairie Voles. Int J Mol Sci 2023;24. [PMID: 36675193 DOI: 10.3390/ijms24021677] [Reference Citation Analysis]
5 Kirschner SK, Ghane P, Park JK, Simbo SY, Ivanov I, Braga-Neto UM, Ten Have GAM, Thaden JJ, Engelen MPKJ, Deutz NEP. Short-chain fatty acid production in accessible and inaccessible body pools as assessed by novel stable tracer pulse approach is reduced by aging independent of presence of COPD. Metabolism 2023;141:155399. [PMID: 36642114 DOI: 10.1016/j.metabol.2023.155399] [Reference Citation Analysis]
6 Di Simone SK, Rudloff I, Nold-Petry CA, Forster SC, Nold MF. Understanding respiratory microbiome-immune system interactions in health and disease. Sci Transl Med 2023;15:eabq5126. [PMID: 36630485 DOI: 10.1126/scitranslmed.abq5126] [Reference Citation Analysis]
7 Kono G, Yoshida K, Kokubo E, Ikeda M, Matsubara T, Koyama T, Iwamoto H, Miyaji K. Fermentation Supernatant of Elderly Feces with Inulin and Partially Hydrolyzed Guar Gum Maintains the Barrier of Inflammation-Induced Caco-2/HT29-MTX-E12 Co-Cultured Cells. J Agric Food Chem 2023;71:1510-7. [PMID: 36622307 DOI: 10.1021/acs.jafc.2c06232] [Reference Citation Analysis]
8 Shrestha J, Razavi Bazaz S, Ding L, Vasilescu S, Idrees S, Söderström B, Hansbro PM, Ghadiri M, Ebrahimi Warkiani M. Rapid separation of bacteria from primary nasal samples using inertial microfluidics. Lab Chip 2023. [DOI: 10.1039/d2lc00794k] [Reference Citation Analysis]
9 Lyu Q, Deng H, Wang S, El-seedi H, Cao H, Chen L, Teng H. Dietary supplementation with casein/cyanidin-3-O-glucoside nanoparticles alters the gut microbiota in high-fat fed C57BL/6 mice. Food Chemistry 2023. [DOI: 10.1016/j.foodchem.2023.135494] [Reference Citation Analysis]
10 Liu Z, Li Y, Li N, Wang Y, Li Q, Ge D, Peng G, Zhou M. Dachengqi Decoction alleviates intestinal inflammation in ovalbumin-induced asthma by reducing group 2 innate lymphoid cells in a microbiota-dependent manner. Journal of Traditional and Complementary Medicine 2023. [DOI: 10.1016/j.jtcme.2023.01.003] [Reference Citation Analysis]
11 Comini L, Pasini E, Porta R, Olivares A, Testa C, Scalvini S, Vitacca M. Dysbiosis and leaky gut in hyper-inflated COPD patients: have smoking and exercise training any role? Respiratory Medicine and Research 2023. [DOI: 10.1016/j.resmer.2023.100995] [Reference Citation Analysis]
12 Budden KF, Gellatly SL, Vaughan A, Amorim N, Horvat JC, Hansbro NG, Wood DLA, Hugenholtz P, Dennis PG, Wark PAB, Hansbro PM. Probiotic Bifidobacterium longum subsp. longum Protects against Cigarette Smoke-Induced Inflammation in Mice. Int J Mol Sci 2022;24. [PMID: 36613693 DOI: 10.3390/ijms24010252] [Reference Citation Analysis]
13 Kumar A, Thite S, Wazarkar V, Ayyat K, Gomez Abraham J, Keshavamurthy S. Recent Advances and Outcomes in Heart and Lung Transplantation. Current Challenges and Advances in Organ Donation and Transplantation [Working Title] 2022. [DOI: 10.5772/intechopen.109068] [Reference Citation Analysis]
14 Bikov A, Dragonieri S, Csoma B, Mazzuca C, Finamore P, Rocchi G, Putignani L, Guarino M, Scarlata S. The Role of Gut Bacteriome in Asthma, Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnoea. Microorganisms 2022;10. [PMID: 36557710 DOI: 10.3390/microorganisms10122457] [Reference Citation Analysis]
15 Feehan B, Ran Q, Dorman V, Rumback K, Pogranichniy S, Ward K, Goodband R, Niederwerder MC, Lee STM. Novel Complete Methanogenic Pathways in Longitudinal Genomic Study of Monogastric Age-Associated Archaea.. [DOI: 10.1101/2022.12.03.518977] [Reference Citation Analysis]
16 Dang X, Kang Y, Wang X, Cao W, Li M, He Y, Pan X, Ye K, Xu D. Frequent exacerbators of chronic obstructive pulmonary disease have distinguishable sputum microbiome signatures during clinical stability. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1037037] [Reference Citation Analysis]
17 Krumina A, Bogdanova M, Gintere S, Viksna L. Gut-Lung Microbiota Interaction in COPD Patients: A Literature Review. Medicina (Kaunas) 2022;58. [PMID: 36556962 DOI: 10.3390/medicina58121760] [Reference Citation Analysis]
18 Ling X, Jie W, Qin X, Zhang S, Shi K, Li T, Guo J. Gut microbiome sheds light on the development and treatment of abdominal aortic aneurysm. Front Cardiovasc Med 2022;9:1063683. [PMID: 36505348 DOI: 10.3389/fcvm.2022.1063683] [Reference Citation Analysis]
19 Wang MG, Wu SQ, Zhang MM, He JQ. Urine metabolomics and microbiome analyses reveal the mechanism of anti-tuberculosis drug-induced liver injury, as assessed for causality using the updated RUCAM: A prospective study. Front Immunol 2022;13:1002126. [PMID: 36483548 DOI: 10.3389/fimmu.2022.1002126] [Reference Citation Analysis]
20 Fang J, Gao Y, Zhang M, Jiang Q, Chen C, Gao X, Liu Y, Dong H, Tang S, Li T, Shi X. Personal PM(2.5) Elemental Components, Decline of Lung Function, and the Role of DNA Methylation on Inflammation-Related Genes in Older Adults: Results and Implications of the BAPE Study. Environ Sci Technol 2022;56:15990-6000. [PMID: 36214782 DOI: 10.1021/acs.est.2c04972] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Zhang Z, Yu W, Li G, He Y, Shi Z, Wu J, Ma X, Zhu Y, Zhao L, Liu S, Wei Y, Xue J, Guo S, Gao Z. Characteristics of oral microbiome of healthcare workers in different clinical scenarios: a cross-sectional analysis. BMC Oral Health 2022;22:481. [PMID: 36357898 DOI: 10.1186/s12903-022-02501-x] [Reference Citation Analysis]
22 Ma P, Wang M, Wang Y. Gut microbiota: A new insight into lung diseases. Biomedicine & Pharmacotherapy 2022;155:113810. [DOI: 10.1016/j.biopha.2022.113810] [Reference Citation Analysis]
23 Laiman V, Lo Y, Chen H, Yuan T, Hsiao T, Chen J, Chang C, Lin T, Li S, Chen Y, Heriyanto DS, Chung KF, Chuang K, Ho K, Chang J, Chuang H. Effects of antibiotics and metals on lung and intestinal microbiome dysbiosis after sub-chronic lower-level exposure of air pollution in ageing rats. Ecotoxicology and Environmental Safety 2022;246:114164. [DOI: 10.1016/j.ecoenv.2022.114164] [Reference Citation Analysis]
24 Hu Q, Liu B, Fan Y, Zheng Y, Wen F, Yu U, Wang W. Multi-omics association analysis reveals interactions between the oropharyngeal microbiome and the metabolome in pediatric patients with influenza A virus pneumonia. Front Cell Infect Microbiol 2022;12. [DOI: 10.3389/fcimb.2022.1011254] [Reference Citation Analysis]
25 Wenger NM, Qiao L, Nicola T, Nizami Z, Xu X, Willis KA, Ambalavanan N, Gaggar A, Lal CV. Efficacy of a Probiotic and Herbal Supplement in Models of Lung Inflammation. Microorganisms 2022;10:2136. [DOI: 10.3390/microorganisms10112136] [Reference Citation Analysis]
26 Wang M, Wu S, Zhang M, He J. Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1044808] [Reference Citation Analysis]
27 Lee CY, Dillard LR, Papin JA, Arnold KB. New perspectives into the vaginal microbiome with systems biology. Trends in Microbiology 2022. [DOI: 10.1016/j.tim.2022.09.011] [Reference Citation Analysis]
28 Quan Y, Yin Z, Chen S, Lang J, Han L, Yi J, Zhang L, Yue Q, Tian W, Chen P, Du S, Wang J, Dai Y, Hua H, Zeng J, Li L, Zhao J. The gut-lung axis: Gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin. Front Pharmacol 2022;13:985223. [DOI: 10.3389/fphar.2022.985223] [Reference Citation Analysis]
29 He Y, Li J, Yu W, Zheng Y, Yang D, Xu Y, Zhao L, Ma X, Gong P, Gao Z. Characteristics of lower respiratory tract microbiota in the patients with post-hematopoietic stem cell transplantation pneumonia. Front Cell Infect Microbiol 2022;12:943317. [DOI: 10.3389/fcimb.2022.943317] [Reference Citation Analysis]
30 Wenger NM, Qiao L, Nicola T, Nizami Z, Xu X, Willis KA, Ambalavanan N, Gaggar A, Lal CV. Efficacy of a Probiotic and Herbal Supplement in Models of Lung Inflammation.. [DOI: 10.21203/rs.3.rs-1979619/v1] [Reference Citation Analysis]
31 Chen Z, Shi J, Zhang Y, Zhang J, Li S, Guan L, Jia G. Lipidomics Profiles and Lipid Metabolite Biomarkers in Serum of Coal Workers’ Pneumoconiosis. Toxics 2022;10:496. [DOI: 10.3390/toxics10090496] [Reference Citation Analysis]
32 Li L, Du Y, Wang Y, He N, Wang B, Zhang T. Atractylone Alleviates Ethanol-Induced Gastric Ulcer in Rat with Altered Gut Microbiota and Metabolites. J Inflamm Res 2022;15:4709-23. [PMID: 35996682 DOI: 10.2147/JIR.S372389] [Reference Citation Analysis]
33 Giuriato G, Paneroni M, Venturelli M, Layec G. Strategies targeting the NO pathway to counteract extra-pulmonary manifestations of COPD: A systematic review and meta-analysis. Nitric Oxide 2022;128:59-71. [PMID: 35977691 DOI: 10.1016/j.niox.2022.08.004] [Reference Citation Analysis]
34 Cho Y, Kim J, Pai H, Rho M. Deciphering Resistome in Patients With Chronic Obstructive Pulmonary Diseases and Clostridioides difficile Infections. Front Microbiol 2022;13:919907. [DOI: 10.3389/fmicb.2022.919907] [Reference Citation Analysis]
35 Zhao J, Duan G, Zhu Y, Zhu D. Gut microbiota and transcriptome response of earthworms (Metaphire guillelmi) to polymyxin B exposure. Journal of Environmental Sciences 2022. [DOI: 10.1016/j.jes.2022.07.033] [Reference Citation Analysis]
36 Huang L, Zhang H, Liu Y, Long Y. The Role of Gut and Airway Microbiota in Pulmonary Arterial Hypertension. Front Microbiol 2022;13:929752. [DOI: 10.3389/fmicb.2022.929752] [Reference Citation Analysis]
37 Godbole S, Bowler RP. Metabolome Features of COPD: A Scoping Review. Metabolites 2022;12:621. [PMID: 35888745 DOI: 10.3390/metabo12070621] [Reference Citation Analysis]
38 Sun Q, Li Z, Wang P, Zhao J, Chen S, Sun M. Unveiling the Pathogenic Bacteria Causing Descending Necrotizing Mediastinitis. Front Cell Infect Microbiol 2022;12:873161. [PMID: 35755831 DOI: 10.3389/fcimb.2022.873161] [Reference Citation Analysis]
39 Belyaev VS, Chervinets VM, Chervinets YV. Gut–lung axis. Pulʹmonologiâ (Mosk ) 2022. [DOI: 10.18093/0869-0189-2022-3053] [Reference Citation Analysis]
40 Zhang Y, Gan Y, Wang J, Feng Z, Zhong Z, Bao H, Xiong Q, Wang R. Dysbiosis of Gut Microbiota and Intestinal Barrier Dysfunction in Pigs with Pulmonary Inflammation Induced by Mycoplasma hyorhinis Infection. mSystems 2022;:e0028222. [PMID: 35699454 DOI: 10.1128/msystems.00282-22] [Reference Citation Analysis]
41 Chen Z, Shi J, Zhang Y, Zhang J, Li S, Guan L, Jia G. Screening of Serum Biomarkers of Coal Workers' Pneumoconiosis by Metabolomics Combined with Machine Learning Strategy. Int J Environ Res Public Health 2022;19:7051. [PMID: 35742299 DOI: 10.3390/ijerph19127051] [Reference Citation Analysis]
42 Mao J, Li Y, Bian Q, Xuan Y, Li J, Wang Z, Feng S, Liu X, Tian Y, Li S. The Bufei Jianpi Formula Improves Mucosal Immune Function by Remodeling Gut Microbiota Through the SCFAs/GPR43/NLRP3 Pathway in Chronic Obstructive Pulmonary Disease Rats. COPD 2022;Volume 17:1285-98. [DOI: 10.2147/copd.s359428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Jiang J, Mei J, Jiang S, Zhang J, Wang L, Yuan J, Yi S, Ma Y, Liu Y. Lung cancer shapes commensal bacteria via exosome-like nanoparticles. Nano Today 2022;44:101451. [DOI: 10.1016/j.nantod.2022.101451] [Reference Citation Analysis]
44 Bae SS, Dong TS, Wang J, Lagishetty V, Katzka W, Jacobs JP, Charles-Schoeman C. Altered Gut Microbiome in Patients With Dermatomyositis. ACR Open Rheumatol 2022. [PMID: 35615912 DOI: 10.1002/acr2.11436] [Reference Citation Analysis]
45 Zolnikova OY, Reshetova MS, Ivanova MN, Ivashkin VT. Metabolomic profiles as a new understanding of disease processes. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2022;32:46-52. [DOI: 10.22416/1382-4376-2022-32-1-46-52] [Reference Citation Analysis]
46 Bulanda E, Wypych TP. Bypassing the Gut-Lung Axis via Microbial Metabolites: Implications for Chronic Respiratory Diseases. Front Microbiol 2022;13:857418. [PMID: 35591998 DOI: 10.3389/fmicb.2022.857418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Jiao J, Tang Q, Wang T, Fan J, Zhang T, Bi K, Li Q, Liu R. The therapeutic effect of Xuanbai Chengqi Decoction on chronic obstructive pulmonary disease with excessive heat in the lung and fu-organs based on gut and lung microbiota as well as metabolic profiles. Journal of Chromatography B 2022;1198:123250. [DOI: 10.1016/j.jchromb.2022.123250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Engelen MPKJ. Editorial: The role of targeted nutritional modulation alongside exercise rehabilitation to improve systemic health outcomes in chronic diseases. Curr Opin Clin Nutr Metab Care 2022;25:133-5. [PMID: 35762171 DOI: 10.1097/MCO.0000000000000827] [Reference Citation Analysis]
49 Wang Z, Bai C, Hu T, Luo C, Yu H, Ma X, Liu T, Gu X. Emerging trends and hotspot in gut-lung axis research from 2011 to 2021: a bibliometrics analysis. Biomed Eng Online 2022;21:27. [PMID: 35449051 DOI: 10.1186/s12938-022-00987-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Shi Y, Wang P, Zhou D, Huang L, Zhang L, Gao X, Maitiabula G, Wang S, Wang X. Multi-Omics Analyses Characterize the Gut Microbiome and Metabolome Signatures of Soldiers Under Sustained Military Training. Front Microbiol 2022;13:827071. [PMID: 35401452 DOI: 10.3389/fmicb.2022.827071] [Reference Citation Analysis]
51 Sexton RE, Uddin MH, Bannoura S, Khan HY, Mzannar Y, Li Y, Aboukameel A, Al-Hallak MN, Al-Share B, Mohamed A, El-Rayes B, Azmi AS. Connecting the Human Microbiome and Pancreatic Cancer. Cancer Metastasis Rev 2022. [PMID: 35366155 DOI: 10.1007/s10555-022-10022-w] [Reference Citation Analysis]
52 Qu L, Cheng Q, Wang Y, Mu H, Zhang Y. COPD and Gut–Lung Axis: How Microbiota and Host Inflammasome Influence COPD and Related Therapeutics. Front Microbiol 2022;13:868086. [DOI: 10.3389/fmicb.2022.868086] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
53 Mindt BC, Digiandomenico A. Microbiome Modulation as a Novel Strategy to Treat and Prevent Respiratory Infections. Antibiotics 2022;11:474. [DOI: 10.3390/antibiotics11040474] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
54 Liu Y, Teo SM, Meric G, Tang HH, Zhu Q, Sanders JG, Vazquez-baeza Y, Verspoor K, Vartiainen VA, Jousilahti P, Lahti L, Niiranen T, Havulinna AS, Knight R, Salomaa V, Inouye M. The gut microbiome is a significant risk factor for future chronic lung disease.. [DOI: 10.1101/2022.03.22.22272736] [Reference Citation Analysis]
55 Li Z, Li Y, Sun Q, Wei J, Li B, Qiu Y, Liu K, Shao D, Ma Z. Targeting the Pulmonary Microbiota to Fight against Respiratory Diseases. Cells 2022;11:916. [PMID: 35269538 DOI: 10.3390/cells11050916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Gebrayel P, Nicco C, Al Khodor S, Bilinski J, Caselli E, Comelli EM, Egert M, Giaroni C, Karpinski TM, Loniewski I, Mulak A, Reygner J, Samczuk P, Serino M, Sikora M, Terranegra A, Ufnal M, Villeger R, Pichon C, Konturek P, Edeas M. Microbiota medicine: towards clinical revolution. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03296-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
57 Huang Q, Wu X, Gu Y, Wang T, Zhan Y, Chen J, Zeng Z, Lv Y, Zhao J, Xie J. Detection of the Disorders of Glycerophospholipids and Amino Acids Metabolism in Lung Tissue From Male COPD Patients. Front Mol Biosci 2022;9:839259. [DOI: 10.3389/fmolb.2022.839259] [Reference Citation Analysis]
58 Alexandrova Y, Costiniuk CT, Jenabian MA. Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection. Front Immunol 2021;12:808722. [PMID: 35058937 DOI: 10.3389/fimmu.2021.808722] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
59 Galaris A, Fanidis D, Stylianaki E, Harokopos V, Kalantzi A, Moulos P, Dimas AS, Hatzis P, Aidinis V. Obesity Reshapes the Microbial Population Structure along the Gut-Liver-Lung Axis in Mice. Biomedicines 2022;10:494. [DOI: 10.3390/biomedicines10020494] [Reference Citation Analysis]
60 Lai HC, Lin TL, Chen TW, Kuo YL, Chang CJ, Wu TR, Shu CC, Tsai YH, Swift S, Lu CC. Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide. Gut 2022;71:309-21. [PMID: 33687943 DOI: 10.1136/gutjnl-2020-322599] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 44.0] [Reference Citation Analysis]
61 Woodall CA, McGeoch LJ, Hay AD, Hammond A. Respiratory tract infections and gut microbiome modifications: A systematic review. PLoS One 2022;17:e0262057. [PMID: 35025938 DOI: 10.1371/journal.pone.0262057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Mathew J, Nickel NP. Cardiovascular Morbidity in Individuals with Impaired FEV1. Curr Cardiol Rep 2022. [PMID: 35038132 DOI: 10.1007/s11886-022-01636-1] [Reference Citation Analysis]
63 Chiu YC, Lee SW, Liu CW, Lan TY, Wu LS. Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study. Respir Res 2022;23:10. [PMID: 35033061 DOI: 10.1186/s12931-022-01928-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
64 Moutsoglou DM. 2021 ATS BEAR Cage Winning Proposal: Microbiome Transplant in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 2021. [PMID: 34758276 DOI: 10.1164/rccm.202108-1833ED] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
65 Nucera F, Hansbro PM, Paudel KR, Casolaro V, Appanna R, Kirkham P, Adcock IM, Caramori G. Role of autoimmunity in the pathogenesis of chronic obstructive pulmonary disease and pulmonary emphysema. Translational Autoimmunity 2022. [DOI: 10.1016/b978-0-323-85415-3.00003-9] [Reference Citation Analysis]
66 Wang W, Mao B, Liu Y, Gu S, Lu H, Bai J, Liang S, Yang J, Li J, Su X, Hu H, Wang C, Xu J. Altered fecal microbiome and metabolome in adult patients with non-cystic fibrosis bronchiectasis. Respir Res 2022;23:317. [DOI: 10.1186/s12931-022-02229-w] [Reference Citation Analysis]
67 Aganetti MA, Cruz CS, Galvão I, Engels DF, Ricci MF, Vieira AT. The Gut Microbiota and Immunopathophysiology. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00128-6] [Reference Citation Analysis]
68 Moitra S, Bandyopadhyay A, Lacy P. Metabolomics of Respiratory Diseases. Handbook of Experimental Pharmacology 2022. [DOI: 10.1007/164_2022_614] [Reference Citation Analysis]
69 Li N, Dobrev D. Cardiac Inflammasome and Arrhythmia. Cardiovascular Signaling in Health and Disease 2022. [DOI: 10.1007/978-3-031-08309-9_9] [Reference Citation Analysis]
70 He Y, Yu W, Ning P, Luo Q, Zhao L, Xie Y, Yu Y, Ma X, Chen L, Zheng Y, Gao Z. Shared and Specific Lung Microbiota with Metabolic Profiles in Bronchoalveolar Lavage Fluid Between Infectious and Inflammatory Respiratory Diseases. JIR 2022;Volume 15:187-98. [DOI: 10.2147/jir.s342462] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
71 Wang Y, Li N, Li Q, Liu Z, Li Y, Kong J, Dong R, Ge D, Li J, Peng G. Xuanbai Chengqi Decoction Ameliorates Pulmonary Inflammation via Reshaping Gut Microbiota and Rectifying Th17/Treg Imbalance in a Murine Model of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2021;16:3317-35. [PMID: 34916790 DOI: 10.2147/COPD.S337181] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
72 Osborn LJ, Orabi D, Goudzari M, Sangwan N, Banerjee R, Brown AL, Kadam A, Gromovsky AD, Linga P, Cresci GAM, Mak TD, Willard BB, Claesen J, Brown JM. A Single Human-Relevant Fast Food Meal Rapidly Reorganizes Metabolomic and Transcriptomic Signatures in a Gut Microbiota-Dependent Manner. Immunometabolism 2021;3:e210029. [PMID: 34804604 DOI: 10.20900/immunometab20210029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Yang Y, Du L, Shi D, Kong C, Liu J, Liu G, Li X, Ma Y. Dysbiosis of human gut microbiome in young-onset colorectal cancer. Nat Commun 2021;12:6757. [PMID: 34799562 DOI: 10.1038/s41467-021-27112-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
74 Gao B, Zhu Y, Gao N, Shen W, Stärkel P, Schnabl B. Integrative Analysis of Metabolome and Microbiome in Patients with Progressive Alcohol-Associated Liver Disease. Metabolites 2021;11:766. [PMID: 34822424 DOI: 10.3390/metabo11110766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
75 Li N, Dai Z, Wang Z, Deng Z, Zhang J, Pu J, Cao W, Pan T, Zhou Y, Yang Z, Li J, Li B, Ran P. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease. Respir Res 2021;22:274. [PMID: 34696775 DOI: 10.1186/s12931-021-01872-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
76 Kelly RS, Stewart ID, Bayne H, Kachroo P, Spiro Iii A, Vokonas P, Sparrow D, Weiss ST, Knihtilä HM, Litonjua AA, Wareham NJ, Langenberg C, Lasky-Su JA. Metabolomic differences in lung function metrics: evidence from two cohorts. Thorax 2021:thoraxjnl-2020-216639. [PMID: 34650005 DOI: 10.1136/thoraxjnl-2020-216639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Dobric A, De Luca SN, Spencer SJ, Bozinovski S, Saling MM, McDonald CF, Vlahos R. Novel pharmacological strategies to treat cognitive dysfunction in chronic obstructive pulmonary disease. Pharmacol Ther 2021;:108017. [PMID: 34626675 DOI: 10.1016/j.pharmthera.2021.108017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Gawałko M, Agbaedeng TA, Saljic A, Müller DN, Wilck N, Schnabel R, Penders J, Rienstra M, van Gelder I, Jespersen T, Schotten U, Crijns HJGM, Kalman JM, Sanders P, Nattel S, Dobrev D, Linz D. Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications. Cardiovasc Res 2021:cvab292. [PMID: 34550344 DOI: 10.1093/cvr/cvab292] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
79 Morris S, Wright K, Malyla V, Britton WJ, Hansbro PM, Cholan PM, Oehlers SH. Exposure to the gut microbiota from cigarette smoke-exposed mice exacerbates cigarette smoke extract-induced inflammation in zebrafish larvae.. [DOI: 10.1101/2021.09.20.461170] [Reference Citation Analysis]
80 Szalontai K, Gémes N, Furák J, Varga T, Neuperger P, Balog JÁ, Puskás LG, Szebeni GJ. Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer. J Clin Med 2021;10:2889. [PMID: 34209651 DOI: 10.3390/jcm10132889] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
81 Kirschner SK, Deutz NEP, Engelen MPKJ. Intestinal dysfunction in chronic disease. Curr Opin Clin Nutr Metab Care 2021;24:464-72. [PMID: 34138768 DOI: 10.1097/MCO.0000000000000780] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Iorio A, Biazzo M, Gardini S, Muda AO, Perno CF, Dallapiccola B, Putignani L. Cross-correlation of virome-bacteriome-host-metabolome to study respiratory health. Trends Microbiol 2021:S0966-842X(21)00122-0. [PMID: 34052095 DOI: 10.1016/j.tim.2021.04.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
83 Espírito Santo C, Caseiro C, Martins MJ, Monteiro R, Brandão I. Gut Microbiota, in the Halfway between Nutrition and Lung Function. Nutrients 2021;13:1716. [PMID: 34069415 DOI: 10.3390/nu13051716] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
84 Feng T, Ding H, Wang J, Xu W, Liu Y, Kenéz Á. Alterations of Serum Metabolites and Fecal Microbiota Involved in Ewe Follicular Cyst. Front Microbiol 2021;12:675480. [PMID: 34054784 DOI: 10.3389/fmicb.2021.675480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Healy C, Munoz-Wolf N, Strydom J, Faherty L, Williams NC, Kenny S, Donnelly SC, Cloonan SM. Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease. Respir Res 2021;22:133. [PMID: 33926483 DOI: 10.1186/s12931-021-01722-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
86 Qi X, Zhang L, Xu J, Tao Z, Wang X, Qiu Y, Pan T, Liu Z, Qu H, Tan R, Liu J. Association of Increased Circulating Acetic Acid With Poor Survival in Pseudomonas aeruginosa Ventilator-Associated Pneumonia Patients. Front Cell Infect Microbiol 2021;11:669409. [PMID: 33996639 DOI: 10.3389/fcimb.2021.669409] [Reference Citation Analysis]
87 Chiu YC, Lee SW, Liu CW, Lin RC, Huang YC, Lan TY, Wu LS. Comprehensive profiling of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity. PLoS One 2021;16:e0249944. [PMID: 33836012 DOI: 10.1371/journal.pone.0249944] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
88 Hamilton-Williams EE, Lorca GL, Norris JM, Dunne JL. A Triple Threat? The Role of Diet, Nutrition, and the Microbiota in T1D Pathogenesis. Front Nutr 2021;8:600756. [PMID: 33869260 DOI: 10.3389/fnut.2021.600756] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
89 Xie XQ, Geng Y, Guan Q, Ren Y, Guo L, Lv Q, Lu ZM, Shi JS, Xu ZH. Influence of Short-Term Consumption of Hericium erinaceus on Serum Biochemical Markers and the Changes of the Gut Microbiota: A Pilot Study. Nutrients 2021;13:1008. [PMID: 33800983 DOI: 10.3390/nu13031008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
90 Ruuskanen MO, Åberg F, Männistö V, Havulinna AS, Méric G, Liu Y, Loomba R, Vázquez-Baeza Y, Tripathi A, Valsta LM, Inouye M, Jousilahti P, Salomaa V, Jain M, Knight R, Lahti L, Niiranen TJ. Links between gut microbiome composition and fatty liver disease in a large population sample. Gut Microbes 2021;13:1-22. [PMID: 33651661 DOI: 10.1080/19490976.2021.1888673] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
91 Hernandez-Baixauli J, Puigbò P, Torrell H, Palacios-Jordan H, Ripoll VJR, Caimari A, Del Bas JM, Baselga-Escudero L, Mulero M. A Pilot Study for Metabolic Profiling of Obesity-Associated Microbial Gut Dysbiosis in Male Wistar Rats. Biomolecules 2021;11:303. [PMID: 33670496 DOI: 10.3390/biom11020303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
92 Morris S, Wright K, Malyla V, Britton WJ, Hansbro PM, Manuneedhi Cholan P, Oehlers SH. Exposure to the gut microbiota from cigarette smoke-exposed mice exacerbates cigarette smoke extract-induced inflammation in zebrafish larvae. Current Research in Immunology 2021;2:229-36. [DOI: 10.1016/j.crimmu.2021.12.001] [Reference Citation Analysis]
93 References. Microbial Metabolism and Disease 2021. [DOI: 10.1016/b978-0-323-88445-7.16001-4] [Reference Citation Analysis]